Trademarkia Logo

Canada

C$
Trademark Search in Canada
EVOLUTION DIAMONDS DESIGN (COLOR)

View On IC.GC.CA

EVOLUTION DIAMONDS DESIGN (COLOR)
REGISTERED

on 14 Nov 2019

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

Route 206 & Province Line RoadPrinceton, NJ 08543

US

Serial Number

1731055 filed on 3rd Jun 2015

Registration Number

TMA1063153 registered on 14th Nov 2019

Registration expiry Date

14th Nov 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

EVOLUTION DIAMONDS DESIGN (COLOR)

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cance Read More

Vienna Information

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 2

Surfaces or backgrounds covered with lozenge shapesSurfaces ou fonds couverts de losanges

25 . 7 . 3

Surfaces or backgrounds covered with squares or rectangles (except a 25.7.4)Surfaces ou fonds couverts de carrés ou de rectangles (excepté a 25.7.4)

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 5

VioletViolet

29 . 1 . 2

Yellow, goldJaune, or

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection, hepatitis; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents.

Classification kind code

10

Class [042]
Pharmaceutical research and development services

Classification kind code

10

Mark Details

Serial Number

1731055

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 30th Nov 2016		Advertised
Submitted for opposition 26
on 10th Nov 2016		Approved
Submitted for opposition 27
on 20th Sept 2016		Approval Notice Sent
Submitted for opposition 68
on 25th Feb 2016		Rep for Service Name Changed
Submitted for opposition 67
on 25th Feb 2016		Agent Name Changed
Submitted for opposition 22
on 28th Jan 2016		Search Recorded
Submitted for opposition 20
on 28th Jan 2016		Examiner's First Report
Submitted for opposition 31
on 5th Jun 2015		Formalized
Submitted for opposition 30
on 3rd Jun 2015		Filed
Submitted for opposition 1
on 3rd Jun 2015		Created